14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:SCLN
Delisted

SciClone Pharmaceuticals Fund Price (Quote)

$11.15
+0 (+0%)
At Close: Oct 31, 2017

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 31st Oct 2017 SCLN stock ended at $11.15. During the day the stock fluctuated 0.448% from a day low at $11.15 to a day high of $11.20.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical SciClone Pharmaceuticals prices

Date Open High Low Close Volume
Oct 31, 2017 $11.15 $11.20 $11.15 $11.15 2 224 627
Oct 30, 2017 $11.15 $11.20 $11.15 $11.15 2 224 627
Oct 27, 2017 $11.15 $11.20 $11.15 $11.15 2 224 627
Oct 26, 2017 $11.15 $11.20 $11.15 $11.15 2 224 627
Oct 25, 2017 $11.15 $11.20 $11.15 $11.15 2 224 627
Oct 24, 2017 $11.15 $11.20 $11.15 $11.15 2 224 627
Oct 23, 2017 $11.15 $11.20 $11.15 $11.15 2 224 627
Oct 20, 2017 $11.15 $11.15 $11.15 $11.15 0
Oct 19, 2017 $11.15 $11.15 $11.15 $11.15 0
Oct 18, 2017 $11.15 $11.15 $11.15 $11.15 0
Oct 17, 2017 $11.15 $11.15 $11.15 $11.15 0
Oct 16, 2017 $11.15 $11.15 $11.15 $11.15 0
Oct 13, 2017 $11.15 $11.20 $11.15 $11.15 2 222 148
Oct 12, 2017 $11.15 $11.20 $11.15 $11.15 220 043
Oct 11, 2017 $11.10 $11.20 $11.07 $11.15 678 324
Oct 10, 2017 $11.15 $11.15 $11.05 $11.05 605 383
Oct 09, 2017 $11.20 $11.20 $11.10 $11.10 182 849
Oct 06, 2017 $11.20 $11.20 $11.15 $11.15 87 627
Oct 05, 2017 $11.15 $11.20 $11.15 $11.20 197 034
Oct 04, 2017 $11.15 $11.20 $11.10 $11.15 260 596
Oct 03, 2017 $11.15 $11.20 $11.10 $11.13 325 485
Oct 02, 2017 $11.20 $11.20 $11.10 $11.15 696 925
Sep 29, 2017 $11.15 $11.20 $11.10 $11.20 633 855
Sep 28, 2017 $11.15 $11.19 $11.12 $11.15 517 918
Sep 27, 2017 $11.15 $11.20 $11.12 $11.15 570 887
Click to get the best stock tips daily for free!

About SciClone Pharmaceuticals

SciClone Pharmaceuticals, Inc., a specialty pharmaceutical company, provides therapies for oncology, infectious diseases, and cardiovascular disorders in the People’s Republic of China, the United States, and Hong Kong. Its lead product is ZADAXIN, which is used for the treatment of hepatitis B and hepatitis C viruses, and certain cancers, as well as for use as an immune system enhancer. In addition, the company focuses on developing ZADAXIN for... SCLN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT